Literature DB >> 6292499

Biosynthesis of virus-specific proteins in cells infected with infectious bursal disease virus and their significance as structural elements for infectious virus and incomplete particles.

H Müller, H Becht.   

Abstract

It has previously been shown that infectious bursal disease virus is a naked icosahedral particle with a diameter of about 60 nm and a genome consisting of two segments of double-stranded RNA (Müller et al., J. Virol. 31:584-589, 1979). One of the two major structural polypeptides (molecular weight, 40,000) of this virus could not be found in lysates of infected cells; it is derived from a precursor polypeptide demonstrable inside the cells in relatively large quantities and seems to be processed during virus assembly or later. The precursor molecule is regularly present in the infectious virus particle (buoyant density, 1.33 g/ml) in minor proportions, but it represents an outstanding structural element of incomplete noninfectious particles ("top components"; buoyant density, 1.29 g/ml) which contain viral RNA. This type of incomplete particles is mainly produced by chicken embryo fibroblasts in contrast to lymphoid cells from the bursa of Fabricius. Precursor-product relationships also seem to exist in the biosynthesis of the other viral polypeptides. In contrast to some other viruses with a segmented double-stranded RNA genome, none of the structural proteins of infectious bursal disease virus is appreciably glycosylated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292499      PMCID: PMC256273     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Synthesis of Rauscher murine leukemia virus-specific polypeptides in vitro.

Authors:  A L Gielkens; D Van Zaane; H P Bloemers; H Bloemendal
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

3.  Structural and growth characteristics of infectious bursal disease virus.

Authors:  H Nick; D Cursiefen; H Becht
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

4.  Evidence for a glycoprotein in reovirus.

Authors:  G Krystal; J Perrault; A F Graham
Journal:  Virology       Date:  1976-07-15       Impact factor: 3.616

5.  Effect of Concanavalin A on cells infected with enveloped RNA viruses.

Authors:  H Becht; R Rott; H D Klenk
Journal:  J Gen Virol       Date:  1972-01       Impact factor: 3.891

6.  High capacity chemisorbents for protein immobilization.

Authors:  J Porath; L Sundberg
Journal:  Nat New Biol       Date:  1972-08-30

7.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

8.  Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro.

Authors:  G Lundgren; C F Zukoski; G Möller
Journal:  Clin Exp Immunol       Date:  1968-10       Impact factor: 4.330

9.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

10.  Chemical coupling of proteins to agarose.

Authors:  J Porath; R Axen; S Ernback
Journal:  Nature       Date:  1967-09-30       Impact factor: 49.962

View more
  25 in total

1.  A second form of infectious bursal disease virus-associated tubule contains VP4.

Authors:  H Granzow; C Birghan; T C Mettenleiter; J Beyer; B Köllner; E Mundt
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Genome assembly and particle maturation of the birnavirus infectious pancreatic necrosis virus.

Authors:  Rodrigo A Villanueva; José L Galaz; Juan A Valdés; Matilde M Jashés; Ana María Sandino
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 3.  Infectious bursal disease virus: a review of molecular basis for variations in antigenicity and virulence.

Authors:  M M Nagarajan; F S Kibenge
Journal:  Can J Vet Res       Date:  1997-04       Impact factor: 1.310

4.  Myristoylation of budgerigar fledgling disease virus capsid protein VP2.

Authors:  M Schmidt; H Müller; M F Schmidt; R Rott
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

5.  VP5 of infectious bursal disease virus is not essential for viral replication in cell culture.

Authors:  E Mundt; B Köllner; D Kretzschmar
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Capsid symmetry of viruses of the proposed Birnavirus group.

Authors:  M Ozel; H Gelderblom
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

7.  C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly.

Authors:  J R Castón; J L Martínez-Torrecuadrada; A Maraver; E Lombardo; J F Rodríguez; J I Casal; J L Carrascosa
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Mapping of cross-reacting and serotype-specific epitopes on the VP3 structural protein of the infectious bursal disease virus (IBDV).

Authors:  G N Mahardika; H Becht
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

9.  Biological roles of the major capsid proteins and relationships between the two existing serotypes of infectious bursal disease virus.

Authors:  S K Reddy; A Silim; M J Ratcliffe
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus.

Authors:  C D Bayliss; R W Peters; J K Cook; R L Reece; K Howes; M M Binns; M E Boursnell
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.